Mold-Tek Packaging Limited has informed the Exchange regarding 'Updates'.
MOLDTKPAC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.1 pts less than its Packaging peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mold-Tek Packaging reported strong FY 2025-26 results with revenue growing 13.48% to ₹886.61 crores from ₹781.32 crores. PAT increased 20.35% to ₹72.87 crores, while EBITDA rose 20.59% to approximately ₹217.35 crores. Sales volumes grew 11.39% to 42,629 MT. The standout performer was the Pharma Packs segment with volume growth of 208.96%, reaching a projected turnover of ₹35 crores. The company consolidated its Hyderabad manufacturing from 5 units to 2, which management expects to yield full operational and financial benefits from FY 2026-27. Statutory auditors M. Anandam & Co. issued an unmodified (clean) opinion on the financial statements, and no going concern or qualification issues were raised. The Board also declared an interim dividend of ₹2.00 per share (40% on face value of ₹5).
The company delivered robust double-digit growth in both revenue and profitability, with EBITDA margin expansion driving PAT growth of over 20%. The clean audit opinion, strong segmental performance particularly in pharma, and manufacturing consolidation all signal positive momentum heading into FY 2026-27 where management targets crossing ₹1,000 crores in turnover.